SEC Filing Summary: Becton, Dickinson and Company (8-K)
Business Context and Reporting Period
This Form 8-K Current Report was filed on January 24, 2008, by Becton, Dickinson and Company (BD). The filing serves to furnish a press release (Exhibit 99.1) containing financial results for the first quarter of fiscal year 2007. The report focuses on reconciling non-GAAP financial measures with U.S. GAAP results to provide investors with a clearer view of underlying operational performance.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Instead, it details the methodology for presenting adjusted financial metrics:
- Revenues: Presented at constant foreign exchange rates to remove the impact of currency fluctuations.
- Operating Income: Adjusted to exclude the in-process research and development (R&D) charge related to the acquisition of TriPath Imaging, Inc.
- Effective Tax Rate: Adjusted to exclude the non-tax-deductible impact of the TriPath in-process R&D charge.
- Income from Continuing Operations: Adjusted to exclude the TriPath in-process R&D charge.
- Earnings Per Share (EPS): Adjusted for the first quarter of fiscal 2007 to exclude the TriPath charge, and for the full fiscal year 2007 to exclude charges related to both the TriPath and Plasso Technology, Ltd. acquisitions.
Material Changes and Unusual Items
The primary material change discussed is the impact of acquisition-related charges on reported financial results:
- TriPath Imaging Acquisition: An in-process R&D charge significantly affected reported operating income, effective tax rate, income from continuing operations, and EPS for the first quarter of fiscal 2007. Management considers this outside of ordinary operations.
- Plasso Technology Acquisition: An in-process R&D charge affected reported EPS for the full fiscal year 2007.
- Foreign Exchange: Currency fluctuations are excluded from revenue growth rate calculations to facilitate period-to-period comparisons.
Management Commentary and Outlook
Management utilizes these non-GAAP measures for internal performance evaluation, budget planning, and to provide investors with insight into underlying business trends. The filing emphasizes that:
- Non-GAAP results are not a substitute for GAAP results and should not be viewed in isolation.
- Excluded items (such as acquisition charges) may have a material impact on GAAP net income and cash flows.
- These measures are intended to improve comparability across periods by removing the effects of items considered outside of ordinary operations.
Investor Verification Checklist
- Verify the specific dollar amounts for the TriPath and Plasso in-process R&D charges in the accompanying press release (Exhibit 99.1).
- Review the GAAP reconciliation table to understand the exact impact of these charges on net income and EPS.
- Confirm the constant currency exchange rates used to calculate adjusted revenue growth.
- Assess the tax implications of the non-deductible R&D charges on the effective tax rate.